Nucleic Acids Research, Vol 26, Issue 6 1522-1527, Copyright © 1998 by Oxford University Press
S Naik, JM Paranjape and RH Silverman
RNase L, a key enzyme in the anti-viral activity of interferons, requires
activation by 2',5'-linked oligoadenylates (2-5A) to cleave viral and
cellular single-stranded RNA. Here we demonstrate that 2-5A causes
formation of stable dimers of RNase L in intact human cells as measured
with a mammalian two-hybrid system. Hybrid proteins consisting of the GAL4
DNA binding domain fused to RNase L and the VP16 transactivation domain
fused to RNase L were able to associate and drive transcription of a
reporter gene, but only after cells were transfected with 2-5A. Several
functional forms of 2-5A, such as p3A2'p5'A2'p5'A, were capable of
activating transcription in human HeLa cells. In contrast, p3A2'p5'A, which
can neither activate nor dimerize RNase L, did not induce gene expression.
Evidence for the involvement of the C-terminal region of RNase L in
dimerization was obtained by expressing truncated forms of RNase L. These
findings describe a convenient, high-throughput screening method for RNase
L activators which could lead to the discovery of novel anti-viral and
anti-cancer agents.
ARTICLES
RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates
Department of Cancer Biology, NN1-06, The Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. R. Papa, C. Zhang, K. Shokat, and P. Walter Bypassing a Kinase Activity with an ATP-Competitive Drug Science, November 28, 2003; 302(5650): 1533 - 1537. [Abstract] [Full Text] [PDF] |
||||
